Product
Rurioctocog alfa pegol
2 clinical trials
2 indications
Indication
Hemophilia AIndication
HemophiliaClinical trial
A Phase 1, Single-Site, Open-Label Study to Assess Pharmacokinetics of Efanesoctocog Alfa (BIVV001), Standard Half-Life and Extended Half-Life FVIII After Each Single Intravenous Injection in a Fixed Sequence, in Previously Treated Adults With Severe Hemophilia AStatus: Completed, Estimated PCD: 2021-11-24
Clinical trial
Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using an Online Medical Application Based on a Published Population Model and a Bayesian AlgorithmStatus: Completed, Estimated PCD: 2022-12-22